Result of AGM
Werte in diesem Artikel
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Result of DXS AGM 2024
The Board of DXS International plc ("the Company” or "DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that all resolutions put to shareholders at the Company's annual general meeting ("AGM") held yesterday were duly passed.
All resolutions were passed on a poll and the votes received from shareholders on each resolution put to the AGM are set out below.
Resolution | Votes for * | % | Votes against | % | Votes withheld ** |
Resolution 1 | 13,664,949 | 100.00% | 0 | 0.00% | 0 |
Resolution 2 | 13,664,949 | 100.00% | 0 | 0.00% | 0 |
Resolution 3 | 13,657,059 | 99.94% | 5,000 | 0.04% | 2,890 |
Resolution 4 | 13,659,949 | 99.96% | 5,000 | 0.04% | 0 |
Resolution 5 | 13,609,949 | 99.60% | 55,000 | 0.40% | 0 |
Resolution 6 | 13,659,949 | 99.96% | 5,000 | 0.04% | 0 |
* Includes discretionary votes
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" any of the resolutions
During the AGM, the Company's CEO, David Immelman, provided an update on DXS’s progress. The Presentation is available for download from the Company's website at https://www.dxs-systems.co.uk/corporate-documents.php No new information was provided in this presentation.
The Directors of DXS International plc accept responsibility for this announcement.
Contacts:
David Immelman DXS International plc www.dxs-systems.com | 01252 719800 |
AQSE Corporate Broker and Corporate Advisor Hybridan LLP Claire Louise Noyce | 020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.
Ausgewählte Hebelprodukte auf DXS International
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DXS International
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu DXS International PLC Registered Shs
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu DXS International PLC Registered Shs
Keine Analysen gefunden.